We are dedicated to advancing ALS research by collaborating with sponsors, investigators, and stakeholders. We have extensive experience managing over 1,389 participants across 13 studies and 316 site initiations in 23 countries. Our team of experts covers a wide range of ALS therapies, from small molecules to gene therapy.
Read this fact sheet to learn more about:
- Our comprehensive ALS site network, active incorporation of patient and caregiver perspectives
- Strong relationships with key opinion leaders, broad ALS experience
- Commitment to equity in access to investigational products
- Advanced capabilities in study design and support for complex therapeutic approaches
